Associated thrombophilic defects in essential thrombocythaemia: their relationship with clinical manifestations

Thromb Res. 2003;112(3):131-5. doi: 10.1016/j.thromres.2003.11.012.
No abstract available

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Amino Acid Substitution
  • Antithrombin III / metabolism
  • Child
  • Female
  • Humans
  • Hydroxyurea
  • Male
  • Middle Aged
  • Platelet Aggregation Inhibitors / therapeutic use
  • Protein C / metabolism
  • Prothrombin / genetics
  • Quinazolines / therapeutic use
  • Reference Values
  • Thrombocythemia, Essential / blood*
  • Thrombocythemia, Essential / complications
  • Thrombocythemia, Essential / drug therapy
  • Thrombophilia / complications

Substances

  • Platelet Aggregation Inhibitors
  • Protein C
  • Quinazolines
  • Antithrombin III
  • Prothrombin
  • anagrelide
  • Hydroxyurea